RecruitingNCT03664609

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Sponsor

Boston Scientific Corporation

Enrollment

5,000 participants

Start Date

Mar 12, 2019

Study Type

OBSERVATIONAL

Conditions

Parkinson Disease Dystonia Essential Tremor

Summary

The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

Eligibility

Plain Language Summary

Simplified for easier understanding

This trial is collecting data from patients who have had (or are being considered for) deep brain stimulation (DBS) — a surgical treatment where a small device is implanted in the brain to regulate abnormal nerve signals — to study real-world outcomes and improve future treatment. **You may be eligible if...** - You have already been treated with a deep brain stimulation system, or - You are eligible and being considered for DBS implantation **You may NOT be eligible if...** - No exclusion criteria apply — this study is open to all eligible DBS patients Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDeep Brain Stimulation

Deep Brain Stimulation in patients with Parkinson Disease, Dystonia and Essential Tremor.

Locations(19)

St. Joseph's Hospital & Medical Center

Phoenix, Arizona, United States

University of California, San Francisco

San Francisco, California, United States

University of Miami Hospital

Miami, Florida, United States

University of South Florida

Tampa, Florida, United States

St. Luke's Regional Medical Center

Boise, Idaho, United States

Albany Medical Center

Albany, New York, United States

Wake Forest University School of Medicine

Winston-Salem, North Carolina, United States

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

Swedish Neuroscience Institute

Seattle, Washington, United States

AZ St. Lucas

Ghent, Belgium

AZ Delta

Roeselare, Belgium

Hopital Fondation Adolphe de Rothschild

Paris, France

Uniklinik Köln

Cologne, Germany

Universitaetsklinikum Dusseldorf

Düsseldorf, Germany

Uniklinikum Jena

Jena, Germany

Universitaetsklinikum Schleswig-Holstein

Lübeck, Germany

Universitaetsklinikum Wuerzburg

Würzburg, Germany

Fondazione Istituto Neurologico Casimiro Mondino

Pavia, Italy

Hospital Virgen Del Rocio

Seville, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03664609

Related Trials

The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

NCT034574931 location

World Data on Ambroxol for Patients With GD and GBA Related PD

NCT043889693 locations